Despite new developments in multi-modality treatments, complete resection remains as an absolute requirement for cure of gastrointestinal cancer. We have reported benefits from combined treatment with complete cytoreduction and intraperitoneal chemotherapy. This has been achieved with low morbidity and mortality. Success in the surgical management of peritoneal surface malignancy depends on the surgeon's ability to complete complex cytoreductive procedures so that only microscopic residual disease remains. This paper describes the current strategy that the surgical oncologist should pursue in the treatment of patients with peritoneal carcinomatosis, sarcomatosis and mesothelioma. Technical details required for this surgery include patient position, incision and exposure, complete lysis of adhesion, electroevaporative dissection with irrigation and suction to preserve the translucent quality of tissues, peritonectomy procedures, proper positioning of tubes and drains for intraperitoneal chemotherapy, and reconstructive surgery. Understanding the treatment and mastery of surgical skills to manage the peritoneal surface spread of cancer has led to long-term survival of selected patients. Combination of this treatment strategy with proper patient selection has reduced the mortality and morbidity. The success of cytoreductive surgery and perioperative intraperitoneal chemotherapy depends on a long-term dedication to achieve the full potential of a curative outcome. Our unit has continued to achieve good results over two decades as improved results of treatment have evolved.
INTRODUCTION
surgery at all. Peritoneal seeding is a major cause of surgical treatment Peritoneal carcinomatosis, sarcomatosis and failure leading to death of patients with abdominal and mesothelioma may occur either concomitantly with a pelvic malignancies. Despite curative surgery, 20-30% of primary tumour or as a recurrence in patients who have patients will develop local cancer recurrence. 1, 2 had a prior surgical resection. In the former, Traditionally, locoregional cancer recurrence with dissemination of cancer cells is spontaneous and peritoneal implantation has been difficult to treat; most dependent upon the anatomical site, the histology, size and the depth of invasion by the primary tumour. In the latter, cancer metastases may be caused by spread during surgery. 3 The dissemination of cancer on the surface of Peritoneal seeding is a major cause of surgical cisplatin within the first hour. 16, 17 Despite the greatly enhanced drug cytotoxicity because of high treatment failure among patients with abdominal and pelvic malignancies. Cancer cells may be shed from the concentrations and heat synergy, the technique is effective only in treating small volume peritoneal disease. serosal surfaces prior to surgery and during surgical manipulations. A positive peritoneal fluid cytology has All the patients who undergo cytoreduction surgery proceed on to post-operative intraperitoneal 5-been detected in 25-30% of resectable gastric [4] [5] [6] and colonic cancer. 7 Surgical dissection results in the release fluorouracil. 5-fluorouracil has a rapid first-pass effect through the liver. The use of early post-operative of intraperitoneal cancer cells in 50-60% of cases. 8 These cancer cells were found to be viable and possess the intraperitoneal chemotherapy may be restricted by the patients co-morbidity state. ability to implant. 9, 10 The disruption in the peritoneal lining may also provide a fertile area for tumour implantation as healing and the inflammatory response to occur. 11 The Safety combined use of peritonectomy and peri-operative intraperitoneal chemotherapy is aimed at the complete The cumulative effect on long-term, low-dose eradication of the disease. This new approach requires occupational risk to peri-operative personnel exposed the acquisition of new technical skills to ensure safety to hyperthermic intraperitoneal cytotoxic agents remains and efficacy.
unknown, however, research to date suggests no measurable increased risk. 18 Guidelines for the safe administration and handling to cytotoxic agents are
CURRENT STRATEGY FOR
provided by the National Cancer Institute, the
COMBINED TREATMENT
Occupational Safety and Health Administration, and the Joint Commission on Accreditation of Healthcare Intraperitoneal chemotherapy and cytoreductive surgery
Organization. 19 The safety of all personnel in the are divided into four major steps: electrosurgery for operating room is paramount during the administration tumour resection and peritonectomy; hyperthermic of chemotherapy. The use of eye protection, double intraperitoneal chemotherapy; reconstruction; and early gloving with outer elbow-length gloves secured with post-operative intraperitoneal chemotherapy. The use of sterile tape and impervious gowns are essential to protect dedicated instruments and adherence to specific surgical the operator. Incorporation of a plastic cover within the techniques are essential to achieve optimum results.
sutures to the skin edge prevents droplet contamination by splashes. A smoke evacuation system is used to remove vapours from the chemotherapy in the abdominal
Electrosurgical dissection
cavity. Intra-abdominal dissection is facilitated by electroevaporative surgery using a 0.3-cm ball-tipped diathermy. 12 The electrosurgical generator is set at a 
OPERATIVE PROCEDURE

Chemotherapy
of the lower extremity is on the heel and not on the calf or popliteal crease. The selection of agents for peri-operative intraperitoneal chemotherapy is based on the drug's ability to produce a cytotoxic effect over a short time period and to show Exposure heat synergy. Mitomycin C, doxorubicin and cisplatin have a slow clearance from the peritoneal cavity.
14,15 The A vertical incision is made from the xiphoid to the symphysis pubis to allow maximum exposure; the xiphoid effects of these agents are potentiated by hyperthermia to achieve a maximum cancer cell kill. Pharmacokinetic process is usually excised. During re-operation, excision of old surgical scars from the skin to the peritoneum studies of intraoperative intraperitoneal chemotherapy report an absorption of 75-90% of the mitomycin C and including the umbilicus, reduces the risk of recurrence 
Right and left upper quadrant
City, MI, USA) improves the exposure, and multiple peritonectomy angles of retraction can be applied to gain maximum exposure for peritonectomy (Fig. 1) .
The falciform ligament and triangular ligaments of the liver are removed at the start of the operation. In right upper quadrant peritonectomy, peritoneum is stripped
Centripetal surgery
from the posterior rectus sheath in continuum. The dissection removes the peritoneum from the Peritoneal stripping begins at the furthest extent of the tumour and proceeds towards the deepest extent of the undersurface of the right hemidiaphragmatic muscle and fascia, and dissection extends to the bare area of the tumour and the major vessels. This centripetal surgery combines as many as six peritonectomy procedures into liver (Fig. 3) . If the tumour is advanced and has an invasive component, peritoneal stripping of the tendinous portion a single co-ordinated effort. It is necessary to allow optimum clearance and containment of the tumour with of the diaphragm may result in penetration into the pleural cavity. Isolated patches of tumour on the liver minimal bleeding and no damage to vital structures. Tumour manipulation may cause dislodgement of free surface are electrovaporated. A layer of tumour on the liver requires electro-evaporative surgical dissection cancer cells into the peritoneum or resection site. Care is taken to preserve the abdominal rectus muscle during beneath the Glisson's capsule to lift the tumour off the dome of the liver. In the left upper peritonectomy, the peritonectomy but the posterior rectus sheath may be sacrificed.
stripping away of the peritoneum will expose the left hemidiaphragm muscle and tendon, left adrenal gland, distal portion of the pancreas and the cephalad portion The greater omentum is involved early in tumour dissemination within the coelomic space and its removal tumours must be removed to maximize the benefits of peri-operative intraperitoneal chemotherapy (Fig. 2) .
is important to reduce the risk of recurrence even if penetration by chemotherapy in cancerous as compared performed to protect the esophagojejunal anastomosis. The jejunum is transected 20 cm distal to the ligament to normal tissues.
A Tenckhoff inflow catheter (Quinton Spiral Peritoneal of Treitz. The proximal portion of jejunum is brought out to divert bile and digestive enzymes from the Catheter, Quinton, Inc., Seattle, WA, USA) and outflow drains are secured watertight with purse-string sutures gastrointestinal tract. The distal portion is anastomosed with the esophagus using a circular stapler (Ethicon ILS29, on the skin of the abdomen. After priming and testing for leakages with one litre of 1.5% dextrose peritoneal Cincinnati, OH, USA). All anastomoses or ostomies are performed after the administration of intraoperative dialysis solution, a total of three litres of chemotherapy solution are used to wash in the abdomen and pelvis.
intraperitoneal chemotherapy. Before closure the Tenchkoff catheter is placed in the Care is taken to avoid spillage. The perfusate is externally heated to 44-46°C to achieve a core intraperitoneal left upper quadrant close to the ligament of Treitz or in the right subdiaphragmatic space. Drains are positioned fluid temperature of 41-42°C. Hyperthermic chemoperfusion is undertaken for a total of 90 min.
in the pelvic cavity and subdiaphragmatic spaces. The abdomen is then closed in the usual fashion.
RECONSTRUCTIVE SURGERY EARLY POST-OPERATIVE
After performing the colorectal and other anastomoses,
INTRAPERITONEAL
thoracic tubes are inserted in the right and the left CHEMOTHERAPY pleural cavities to evacuate fluid accumulating in the chest following subdiaphragmatic resection. In Intraperitoneal chemotherapy is indicated following the complete resection of appendiceal, colonic, rectal, gastric gastrectomy cases a duodenal exclusion operation is 
PERITONEAL CANCER INDEX
The peritoneal cancer index is a quantitative prognostic score calculated after abdominal exploration and complete adhesiolysis (Fig. 5) . The success of complete cytoreduction and long-term survival can be predicted by grading the distribution and the mass of peritoneal surface cancer. 22 It is not useful in grading minimally (Fig. 6 ).
CYTOREDUCTION SCORE
Patients with complete cytoreduction have a higher chance of long-term survival, but incomplete Another quantitative prognostic score is the completeness of cytoreduction. For gastrointestinal cytoreduction rarely offers cure. In patients with peritoneal seeding from colon cancer a complete cancer, the completeness of cytoreduction score has been defined as follows: CC-0, no visible peritoneal cytoreduction had a 40% 5-year survival; patients with an incomplete cytoreduction had a 0% 5-year survival.
23
carcinomatosis remained after cytoreduction; CC-1, tumour nodules persist after cytoreduction but less than It is important to note that no patient with long-term survival have been reported undergoing surgery alone or surgery plus systemic chemotherapy.
• The two quantitative prognostic indicators useful in the assessment of outcome are the peritoneal cancer index and completeness of cytoreduction
POST-OPERATIVE COMPLICATION
score. Careful patient selection is crucial for the success of the
• Knowledgeable patient selection is necessary in peritonectomy procedure and intraperitoneal order to avoid low-benefit surgery that because of chemotherapy. The most common post-operative its extent carries high morbidity, mortality, and cost. complication is prolonged intestinal ileus and gastric
• Dedication to technical perfection with surgery and paresis. Nasogastric suction is maintained until there is a knowledgeable management of intraperitoneal evidence of bowel function such as passing gas per rectum chemotherapy are essential to the development of and decreasing gastric drainage (less than 750 ml per a programme in peritoneal surface malignancy. day), especially of bile. Total parenteral nutrition is maintained until full caloric oral intake is achieved. A fifth of the patients will require parenteral feeding at home.
DISCUSSION
In the most recent study of 200 patients who had undergone cytoreductive surgery and heated intra-
The successful management of peritoneal surface operative intraperitoneal chemotherapy for peritoneal malignancies depends on several factors: the presence carcinomatosis, peripancreatitis (7.1%) and bowel fistula of co-morbid disease, the disease stage, tumour biology, (4.7%) were the most common reported major the completeness of cancer excision and the elimination complications. 24 Peripancreatitis, a potentially lifeof minimal residual cancer by chemotherapy. The higher threatening condition, occurs more frequently if the success rate associated with the treatment of peritoneum and fat are stripped from the surface of the cystadenocarcinoma, cystic mesothelioma and low-grade pancreas. A high index of suspicion for a peripancreatic sarcomas are attributable to their expansive growth, collection needs to be exercised should the patient with minimal invasion of the underlying structures. In become febrile. Fluid collected from the drain placed at contrast, poorer results obtained with adenocarcinomas the superior aspect of the pancreas should be sent for are related to the infiltrative nature of these tumours. assessment of lipase and amylase levels. The incidence In all conditions, an imperfect peritonectomy will result of fistula formation, anastomotic leak, intestinal necrosis in an early recurrence and treatment failure. and prolonged ileus is reduced with the use of diverting
The surgical procedure for the management of and decompressing ileostomy. Overall, a quarter of the peritoneal malignancies poses a steep learning curve. It is patients had grade III and IV complication. There was technically and physically demanding with long operative less than 2% (3/200) mortality rate.
time and a risk of excessive blood loss. Furthermore, the administration of early post-operative intraperitoneal
SECOND-LOOK OPERATION
chemotherapy may be compromized by the patients' post-operative status. These factors may contribute to A second-look with closure of a diverting ileostomy or poor treatment outcome during the early stages of a jejunostomy at 6-9 months is routinely performed in programme in treating peritoneal surface malignancy one-third of the patients. Eighty percent of the patients and may deter many surgeons. 25 However, the use of are found to have recurrences but have a complete redo electroevaporation surgery has revolutionized the radical cytoreduction in 80% of patients because of the low excision of peritoneal malignancies by minimizing blood peritoneal cancer index.
loss.
Key Points
The pharmacokinetic advantages to intraperitoneal chemotherapy have been well described. 26 The success • Cytoreductive surgery reduces carcinomatosis to of intraperitoneal chemotherapy is dependent on the microscopic residual disease so that peri-operative elimination of residual cancer cells following complete intraperitoneal chemotherapy is able to eradicate resection. However, the benefit of intraperitoneal cancer.
chemotherapy is localized to the surface area of infusion.
• Centripetal surgery is initiated at the furthermost Drug diffusion occurs but the tissue penetration is limited extent of the tumour, it works in a retroperitoneal to 1-2 mm from the surface. [26] [27] [28] We believe that the plane towards the centre of the abdomen and open technique is superior to the closed technique pelvis to complete an optimal cytoreduction.
in allowing adequate and uniform exposure of all the • Hyperthermic intraoperative intraperitoneal abdominal and pelvic surfaces to intraperitoneal chemotherapy enhances the cytotoxicity of the chemotherapy, as demonstrated by the dye studies. In drugs, increases their penetration into cancerous contrast many areas are unstained with dye when the tissue, and promotes uniform distribution.
closed technique is employed, especially the lesser 
